APA (7th ed.) Citation

Q, C., J, L., X, X., H, Z., Z, X., & Y, P. (2026). Ethical and Regulatory Considerations in the Clinical Translation of Pluripotent Stem Cell-Derived NK Cell Therapies. Cell proliferation, 59(4), e70129. https://doi.org/10.1111/cpr.70129

Chicago Style (17th ed.) Citation

Q, Chen, Lv J, Xie X, Zhu H, Xiao Z, and Peng Y. "Ethical and Regulatory Considerations in the Clinical Translation of Pluripotent Stem Cell-Derived NK Cell Therapies." Cell Proliferation 59, no. 4 (2026): e70129. https://doi.org/10.1111/cpr.70129.

MLA (9th ed.) Citation

Q, Chen, et al. "Ethical and Regulatory Considerations in the Clinical Translation of Pluripotent Stem Cell-Derived NK Cell Therapies." Cell Proliferation, vol. 59, no. 4, 2026, p. e70129, https://doi.org/10.1111/cpr.70129.